Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$423B
| $893M | 0.9% |
3,038,231
+3,057
| +0.1% | +$909K |
|
27
Sanofi
SNY
$104B
| $881M | 0.89% |
17,547,345
+170,342
| +1% | +$7.98M |
|
|
NVO
28
Novo Nordisk
NVO
$211B
| $873M | 0.88% |
30,176,384
-246,216
| -0.8% | -$6.82M |
|
|
RDS.A
29
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $857M | 0.87% |
14,524,781
-47,674
| -0.3% | -$2.78M |
|
30
Oracle
ORCL
$435B
| $846M | 0.85% |
15,963,953
-129,011
| -0.8% | -$7.1M |
|
|
SI
31
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $840M | 0.85% |
12,848,820
+144,692
| +1% | +$9.46M |
|
32
JPMorgan Chase
JPM
$956B
| $831M | 0.84% |
5,959,065
-6,118
| -0.1% | -$785K |
|
33
Caterpillar
CAT
$385B
| $819M | 0.83% |
5,547,111
+170,314
| +3% | +$23.8M |
|
34
AstraZeneca
AZN
$251B
| $816M | 0.82% |
8,185,354
+54,373
| +0.7% | +$5.12M |
|
35
Merck
MRK
$323B
| $809M | 0.82% |
9,316,756
-111,586
| -1% | -$9.17M |
|
36
Novartis
NVS
$298B
| $797M | 0.81% |
8,421,770
+106,786
| +1% | +$9.58M |
|
37
ASML
ASML
$666B
| $749M | 0.76% |
2,531,190
-81,391
| -3% | -$22M |
|
38
iShares MBS ETF
MBB
$38.9B
| $736M | 0.74% |
6,813,131
+363,982
| +6% | +$39.3M |
|
39
GSK
GSK
$104B
| $724M | 0.73% |
12,330,369
+116,299
| +1% | +$6.47M |
|
40
RTX Corp
RTX
$302B
| $714M | 0.72% |
7,575,507
+62,968
| +0.8% | +$5.71M |
|
41
Netflix
NFLX
$318B
| $713M | 0.72% |
22,040,740
-122,550
| -0.6% | -$3.63M |
|
42
UBS Group
UBS
$177B
| $660M | 0.67% |
52,446,303
-44,692
| -0.1% | -$532K |
|
43
Rio Tinto
RIO
$166B
| $654M | 0.66% |
11,016,501
+121,936
| +1% | +$6.61M |
|
44
Procter & Gamble
PG
$340B
| $644M | 0.65% |
5,153,034
+113,519
| +2% | +$13.9M |
|
45
HSBC
HSBC
$354B
| $625M | 0.63% |
15,977,993
+101,497
| +0.6% | +$3.85M |
|
46
Chevron
CVX
$382B
| $624M | 0.63% |
5,179,943
+16,889
| +0.3% | +$1.99M |
|
47
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
| $613M | 0.62% |
19,861,180
+157,394
| +0.8% | +$4.85M |
|
48
ING
ING
$101B
| $601M | 0.61% |
49,914,175
+719,442
| +1% | +$8.24M |
|
49
Eli Lilly
LLY
$1.1T
| $580M | 0.59% |
4,412,010
+105,613
| +2% | +$12.2M |
|
50
AB InBev
BUD
$164B
| $577M | 0.58% |
7,027,848
-13,662
| -0.2% | -$1.14M |
|
Similar funds
Fisher Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fisher Asset Management held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fisher Asset Management's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Fisher Asset Management's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Fisher Asset Management added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Fisher Asset Management's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Fisher Asset Management fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Fisher Asset Management's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Fisher Asset Management opened 78 new positions and closed 83 in Q4 2019.
- Fisher Asset Management's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.